GIM
SRPT icon

Granahan Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Granahan Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-245,866
Closed -$3.27M – 241
2015
Q1 		$3.27M Sell
245,866
-378,646
-61% -$5.05M 0.09% 197
2014
Q4 		$9.04M Sell
624,512
-5,770
-0.9% -$97.7K 0.26% 127
2014
Q3 		$13.3M Sell
630,282
-482
-0.1% -$10.9K 0.41% 88
2014
Q2 		$18.8M Sell
630,764
-12,170
-2% -$385K 0.55% 71
2014
Q1 		$15.4M Buy
642,934
+104,430
+19% +$2.66M 0.42% 92
2013
Q4 		$11M Buy
538,504
+195,344
+57% +$5.8M 0.28% 129
2013
Q3 		$16.2M Sell
343,160
-3,680
-1% -$142K 0.43% 94
2013
Q2 		$13.2M Buy
+346,840
New +$12.4M 0.38% 103

Other funds holding SRPT

CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Granahan Investment Management's SRPT Position: Q2 2015 in Review

Granahan Investment Management sold out of Sarepta Therapeutics (SRPT) in Q2 2015, closing a stake of 245,866 shares — an estimated $3.27M sold.

Granahan Investment Management first reported a position in SRPT in Q2 2013 and held it in 8 quarters. The position peaked at $18.8M in Q2 2014. 130 funds tracked by Wall St. Rank hold SRPT as of Q2 2015.

  • Granahan Investment Management reported no remaining Sarepta Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Granahan Investment Management sold 245,866 Sarepta Therapeutics shares in Q2 2015, an estimated $3.27M.
  • Granahan Investment Management first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 8 quarters.
  • Granahan Investment Management's Sarepta Therapeutics position peaked at $18.8M in Q2 2014.
  • 130 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2015.

Based on Granahan Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.